Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of disulfiram and cisplatin in refractory testicular germ cell cancer
2019-000558-68Phase 2Completed
- Sponsor
- Národný onkologický ústav
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of disulfiram and cisplatin in Germ Cell Testicular Cancer and germ cell tumor (GCT), sponsored by Národný onkologický ústav. Primary endpoint: Overall response rate by RECIST 1.1. Started Mar 2019; status: completed.
02
Drugs
disulfiramcisplatin
03
Conditions
Germ Cell Testicular Cancergerm cell tumor (GCT)
Beyond the preview
Go deeper on 2019-000558-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000558-68.